Structure and regulation of full-length human leucine-rich repeat kinase 1
Riley D. MetcalfeiD, Juliana A. Martinez FiescoiD, Luis Bonet‐PonceiD, Jillian H. KlussiD, Mark CooksoniD, Ping ZhangiD
Abstract
The two human leucine-rich repeat kinases (LRRKs), LRRK1 and LRRK2 are large and unusually complex multi-domain kinases which serve to regulate fundamental cellular processes, with both implicated in human disease. Despite recent experimentally determined structures of LRRK2, the structure and exact molecular mechanisms regulating the activity of the LRRK1, and differences in the regulation of LRRK1 and LRRK2 remain unclear. Here, we report a cryo-EM structure of the LRRK1 monomer, and a lower-resolution cryo-EM map of the LRRK1 dimer. The monomer structure, in which the kinase is in an inactive conformation, reveals key interdomain interfaces which serve to control kinase activity, which are further validated experimentally. Both the LRRK1 monomer and dimer are structurally distinct compared to LRRK2, implying functional differences in both proteins. Overall, our results provide new structural insights into the activation of the human LRRKs for understanding the physiology and pathology of these proteins.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- FWCI
- 0.71
- Field percentile
- top 36%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structure of LRRK1 and mechanisms of autoinhibition and activation
J. M. Reimer, A. M. Dickey, … A. E. Leschziner·bioRxiv·Nov 22, 2022
- Structural basis of human LRRK2 membrane recruitment and activation
H. Zhu, F. Tonelli, … J. Sun·bioRxiv·Apr 26, 2022
- The structural basis for LRRK2's activation and autoinhibition
Amalia C. Villagran Suarez, Kathryn S. Hatch, … Andrés E. Leschziner·CellPeer-reviewed·Aug 10, 2026
- Capturing differences in the regulation of LRRK2 dynamics and conformational states by small molecule kinase inhibitors
J.-H. Weng, W. Ma, … S. S. Taylor·bioRxiv·Oct 24, 2022
- Inhibition of Parkinsons Disease-related LRRK2 by type-I and type-II kinase inhibitors: activity and structures
A. E. Leschziner, M. Sanz Murillo, … S. Mathea·bioRxiv·Sep 7, 2023
- Biophysical analysis reveals autophosphorylation as an important negative regulator of LRRK2 dimerization
G. Guaitoli, X. Zhang, … C. J. Gloeckner·bioRxiv·Aug 11, 2023